Jean-Pierre Sommadossi has sold AVIR and made no open-market buys since Feb 2024
President, CEO and Chair at Atea Pharmaceuticals, Inc.
SEC CIK 0001296995 · Filings on SEC.gov ↗
$0Bought
$453KSold
NoneLast buy
Every filing
2 filings since Feb 2024, newest first
Filings come from SEC EDGAR. Not investment advice.